Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)
<h4>Aims</h4> <p>Hypoglycaemia is a significant risk in insulin treated type 2 diabetes and has been associated with future risk of cardiovascular events. We compared the frequency of low-glucose events using continuous glucose monitoring (CGM) with that of self-reported hypoglyce...
Κύριοι συγγραφείς: | Levy, J, Davies, M, Holman, R |
---|---|
Μορφή: | Journal article |
Έκδοση: |
Elsevier
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023
ανά: Chris Worth, κ.ά.
Έκδοση: (2023-01-01) -
Should continuous glucose monitoring be used to manage neonates at risk of hypoglycaemia?
ανά: Maria-Sofia Kalogeropoulou, κ.ά.
Έκδοση: (2023-03-01) -
Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
ανά: Cull, C, κ.ά.
Έκδοση: (2001) -
Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants
ανά: Passaro Patrizia, κ.ά.
Έκδοση: (2008-07-01) -
Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems
ανά: Huiying Wang, κ.ά.
Έκδοση: (2022-04-01)